We are live on ! Find out more
LA

Lau Associates Portfolio holdings

AUM $201M
1-Year Est. Return 26.29%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+26.29%
3 Year Est. Return
+44.49%
5 Year Est. Return
+59.98%
10 Year Est. Return
AUM
$201M
AUM Growth
+$11.8M
Cap. Flow
+$1.1M
Cap. Flow %
0.55%
Top 10 Hldgs %
53.57%
Holding
99
New
3
Increased
6
Reduced
35
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 22.92%
2 Healthcare 11.95%
3 Consumer Staples 8.61%
4 Energy 8.58%
5 Financials 5.88%

No holdings matched the selected filter criteria.

Similar funds

Lau Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Lau Associates held 99 positions worth $201M, up 6.3% from $189M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Lau Associates's Q4 2019 filing shows 3 new, 6 increased, 35 reduced and 5 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K. The largest sale was Corteva, an estimated $643K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Lau Associates's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K.
  • Lau Associates added most to JPMorgan Ultra-Short Income ETF in Q4 2019, an estimated $2.88M increase.
  • Lau Associates's biggest Q4 2019 reduction was Corteva, cutting an estimated $643K.
  • Lau Associates fully exited AbbVie in Q4 2019, selling an estimated $473K.
  • Lau Associates's ten largest holdings make up 54% of its $201M portfolio in Q4 2019.
  • Lau Associates opened 3 new positions and closed 5 in Q4 2019.
  • Lau Associates's portfolio value rose 6.3% quarter-over-quarter to $201M.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.